Background and Aim: Hepatitis E virus (HEV) may cause chronic liver disease in solid organ transplant recipients. We determined HEV seroprevalence and associated factors in liver transplant recipients. Materials and Methods: Patients followed at the outpatient clinic of liver transplantation between January 2019 and January 2020 were screened retrospectively for HEV serology (HEV immunoglobulin M [IgM] and HEV immunoglobulin G [IgG]). Results: Of the 150 patients (male/female, 104/46; age, 55.4±13.2 years), anti-HEV IgG was positive in 31 (20.7%), and anti-HEV IgM was negative in all. The mean time after liver transplantation (72 [48%] deceased and 78 [52%] living donors) was 81±78.5 months. Drinking water consisted of carboy and tap water in 88 (58.7%) and 62 patients (41.3%), respectively. Of the patients, 120 (80%) and 30 (20%) lived in urban and rural areas, respectively. On comparison, the difference between positive and negative anti-HEV IgG groups in terms of age, place of birth, water supply, and donor type was statistically significant (p=0.007, p=0.000, p=0.034, and p=0.049, respectively). Conclusion: HEV seroprevalence was more frequent in liver transplant recipients compared with the normal population. Older age, water supply, and place of birth were risk factors for HEV seroprevalence.
Background and Aim: Hepatocellular carcinoma (HCC) is one of the most common and most lethal cancers worldwide. The objective of this study was to investigate the relationship between basal parameters and survival characteristics in patients with HCC. Materials and Methods: The records of 1447 HCC patients of a tertiary center during the period 2000-2017 were screened retrospectively. The demographic details; basal clinical, laboratory, and radiological characteristics; treatments; and survival time were recorded and prognostic scores were calculated. Results: A total of 788 patients with HCC (male/female: 623/165; mean age: 60.5±10.9 years) were included in the study. The median length of survival was 26.3 months (95% confidence interval [CI], 22.3-30.4 months). The 5-year survival rate was 28.1%. The number and diameter of the tumors; platelet count; platelet-to-lymphocyte ratio; level of aspartate aminotransferase, alanine aminotransferase, and gamma-glutamyl transferase; portal and hepatic vein involvement; and an alpha-fetoprotein level of
25 August 2025 in Turkish Journal of Gastroenterology
Background/Aims: This study aimed to compare the efficacy of bolus versus infusion administration of terlipressin in patients with acute esophageal variceal bleeding and to elucidate any differences in clinical outcomes between the 2 approaches. Materials and Methods: This prospective study included patients divided into 2 groups. Group 1 received a 2 mg intravenous (IV) bolus followed by 1 mg IV every 4 hours. Group 2 received a 1 mg IV bolus followed by a 4 mg terlipressin infusion over 24 hours. Clinical and laboratory parameters, hospitalization duration, need for blood product transfusion, rebleeding or mortality within 6 weeks, and drug related side effects were evaluated. Results: Among the 46 patients, 23 (50%) received terlipressin as an IV bolus (group 1), and 23 (50%) received it as an infusion (group 2). Treatment failure occurred in 4 patients (8.7%), all from group 1, though the difference was not statistically significant (P = .109). Six patients (13%) experienced rebleeding and death within 6 weeks, with no significant differences in clinical outcomes between the groups. No significant differences in creatinine and sodium levels were observed between the groups at baseline or at the end of treat ment (P = .654). Additionally, no difference in the incidence of portal vein thrombosis was noted between survivors and non-survivors (P = 1.000). Conclusion: As no significant differences in efficacy or safety were observed between bolus and infusion administration, infusion ther apy may be preferred due to its potential benefits in patient comfort and ease of administration. Cite this article as: Şenkaya A, Çelik F, Kurtulmuş Akgün İ, et al. Terlipressin treatment for acute esophageal variceal bleeding: Bolusor infusion? Turk J Gastroenterol. Published online August 25, 2025. doi: 10.5152/tjg.2025.25265.
11 January 2022 in Akademik Gastroenteroloji Dergisi
Giriş ve Amaç: Gastrik polip lümene doğru çıkıntı oluşturan, mukoza veya submukozadan köken alan sesil ya da saplı lezyonlar olarak tanımlanır. Bu çalışmanın amacı, gastroskopi işlemi sırasında tespit edilen poliplerin görülme sıklığının, gastrik polip saptanan hastaların demografik özelliklerinin, poliplerin endoskopik ve histopatolojik özelliklerinin, eşlik eden diğer endoskopik bulguların ve tedavi şekillerinin değerlendirilmesidir. Gereç ve Yöntem: Bu çalışmaya, Haziran 2017 ile Haziran 2020 tarihleri arasında üniversite hastanemiz gastroenteroloji bölümü endoskopi ünitesinde yapılan 13280 gastroskopi işleminde, polip saptanan 80 hasta dahil edildi. Seksen hastada toplam 125 polip saptandı ve retrospektif olarak değerlendirildi. Hastaların yaşı ve cinsiyeti, gastroskopi yapılma nedeni, polip sayısı, poliplerin midedeki lokalizasyonu, polipektomi yöntemi, polip histopatolojisi, Helicobacter pylori pozitifliği, intestinal metaplazi varlığı, atrofik gastrit varlığı, polipektomi sonrası komplikasyon gelişip gelişmediği tarandı. Bulgular: Seksen (%0.6) hasta ve bu hastalarda saptanan toplam 125 polip sonucu değerlendirildi. Hastaların 54’ü (%67.5) kadın ve yaş ortalaması 57.5 ± 12.5 yıldı. Hastaların %51.2’sinde endoskopi yapılma nedeni, başka merkezlerden kliniğimize polipektomi amacıyla yönlendirilmeleriydi. Mide mukoza örneklemesinde hastaların %11.3’ünde Helicobacter pylori pozitifliği, %20’sinde intestinal metaplazi, %21.2’sinde atrofik gastrit mevcuttu. Poliplerin %65.6’sında polip boyutu 10 mm’nin altındaydı. Polipler sırasıyla; en sık korpusta (%54.4), antrumda (%22.4) ve fundusta (%20.8) saptandı. Poliplerin histopatolojisi en sık fundik gland polip (%42.4), hiperplastik polip (%30.4) ve nöroendokrin tümördü (%20.8). En sık uygulanan polipektomi yöntemi poliplerin %51.2’sinde biyopsi forsepsi ile polipektomidir. Hastaların 5’inde (%4) polipektomi komplikasyonu olarak postpolipektomi interprosedürel kanama gelişti. Sonuç: Çalışmamızda mide polip saptanma oranı literatür ile uyumlu bulunmuştur. Endoskopik olarak bazen poliplerin birbirinden ayırt edilmesi zor olabildiğinden mümkün olan her polibe güvenli bir şekilde polipektomi yapılmalı ve komşu mide mukozasından örnekler alınmalıdır.
Giriş ve Amaç: İnlet patch, üst özofagus sfinkterinde veya hemen distalinde yer alan heterotopik gastrik mukoza adasıdır. Bu çalışmada amaç kliniğimizde inlet patch tanısı konulan vakaların sıklığı, demografik, klinik ve endoskopik özelliklerini değerlendirmektir. Gereç ve Yöntem: Bu çalışma Ocak 2015- Mart 2020 tarihleri arasında Gastroenteroloji Bilim Dalında herhangi bir nedenle özofagogastroduodenoskopi yapılıp, inlet patch tanısı konulan 245 hastanın retrospektif değerlendirilmesini içermektedir. Çalışmaya alınan hastaların; yaş, cinsiyet, endoskopi yapılma nedeni, inlet patch lezyonunun boyutu ve sayısı, Barrett özofagus, özofajit ve hiatus hernisi varlığı ve var olan patoloji sonuçları değerlendirilmiştir. Bulgular: İki yüz kırk beş hastada inlet patch bulunmuştur. İki yüz kırk beş hastanın 124’ü (%50.6) kadın, yaş ortalaması 48.64±14.54 yıldır. İnlet patch boyutunun ortalaması 13.32±8.85 (3-40) mm’dir. En sık endoskopi yapılma nedeni 91 (%37.1) hastada dispepsi olarak saptanmıştır. İnlet patch saptanan hastaların endoskopi sırasında 39’unda (%15.9) özofajit, 20’sinde (%8.2) hiatus hernisi ve 6’sında (%2.4) Barrett özofagus görülmüştür. Hastaların 125’inden (%51) biyopsi alınmış olup, 98 (%78.4) hastada patoloji ile uyumlu sonuçlanmıştır. Hastaların endoskopi yapılma nedenleri, Barrett özofagus ve hiatus hernisi varlığı ile inlet patch boyutu arasındaki istatistiksel olarak anlamlı farklılık olduğu saptanmıştır (sırasıyla; p=0.03, p=0.004, p=0016). Sonuç: Herhangi bir nedenle yapılan endoskopilerin %1.24’ünde inlet patch saptanmıştır. Merkezimiz üçüncü basamak bir sağlık kuruluşu olduğundan bu sonucun, Ege Bölgesi’nin inlet patch prevalansını yansıttığını düşünmekteyiz. Fonksiyonel dispepsi, disfaji, nedeni bilinmeyen kronik öksürüğü ve globusu olan hastalarda, servikal özofagus inlet patch açısından dikkatli bir şekilde incelenmelidir.
Background/Objectives: Corrosive substance intake remains a significant public health concern due to its potential for severe gastrointestinal (GI) injury and associated morbidity. Early risk stratification is crucial for appropriate management, yet there is a lack of reliable non-invasive predictors of injury severity. This study aimed to evaluate the clinical characteristics of adult patients with corrosive ingestion and to investigate the correlation between inflammatory markers and endoscopic injury severity. Methods: In this retrospective study, 83 adult patients who underwent esophagogastroduodenoscopy (EGD) following corrosive ingestion between January 2017 and January 2021 were analyzed. Endoscopic injuries were graded using the Zargar classification and categorized as mild (grades 0–2a) or severe (grades 2b–4). Demographic, clinical, endoscopic, and laboratory data, including neutrophil-to-lymphocyte ratio (NLR) and C-reactive protein (CRP) levels, were recorded. The correlation between inflammatory markers and injury severity was assessed, and receiver operating characteristic (ROC) analysis was performed to determine diagnostic accuracy. Results: Among the patients, 55.4% were female with a mean age of 41.5 ± 17.3 years. Most ingestions were accidental (74.7%), with bleach being the most common agent (41%). Endoscopic injury was detected in 55.4% of patients, predominantly in the stomach and esophagus. Severe injuries were associated with longer intensive care and hospital stays, increased complication rates, and more frequent organ involvement (p < 0.001). A weak but statistically significant correlation was found between injury severity and both NLR (r = 0.357, p = 0.001) and CRP (r = 0.247, p = 0.024). ROC analysis revealed an NLR cut-off of 2.95 (AUC = 0.804) and CRP cut-off of 2.5 (AUC = 0.706) for predicting severe injury. Conclusions: Early endoscopic evaluation remains essential for assessing corrosive injury severity. However, NLR and CRP may serve as useful, non-invasive indicators in predicting injury severity, potentially aiding clinical decision-making, especially in settings where endoscopy is not readily available or is contraindicated.